The project addresses the ethical, legal, and economic implications of predictive medicine for the right to health, focusing on the more specific and current issue of including next-generation prenatal genetic tests in the essential levels of care (LEA) guaranteed by the National Health Service.
The project aims to advance knowledge concerning the current and future landscape of equity in access to prenatal genetic testing. The impact that the research seeks to achieve in this thematic area requires the development of both theoretical and practical knowledge related to the social and institutional context in which scientific and biotechnological innovations take shape and can spread within society, in order to generate the social benefits toward which they are directed.